HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, J. I. Articles by Hatcher, C. R. Search for Related Content PubMed PubMed Citation Articles by Miller, J. I. Articles by Hatcher, C. R., Jr.

Ann Thorac Surg 1985;40:289-293
© 1985 The Society of Thoracic Surgeons

---

Articles

Combined Treatment Approach in Surgical Management of Carcinoma of the Esophagus: A Preliminary Report

From the Joseph B. Whitehead Department of Surgery, Division of Thoracic and Cardiovascular Surgery, Emory University School of Medicine, Atlanta, GA.

^* Address reprint requests to Dr. Miller, 25 Prescott St NE, Atlanta, GA 30308

Surgical management of squamous cell carcinoma of the esophagus continues to be a controversial area in thoracic surgery. In a series of 20 patients, 15 received preoperative chemotherapy with cis-platinum (cisplatin), 2 received cisplatin plus 5-fluorouracil, and 3 received cisplatin plus vinblastine sulfate. Eighteen patients underwent en bloc esophagogastrectomy and postoperative radiation therapy. All patients were staged preoperatively by thoracoabdominal computed axial tomographic scan, bone scan, bronchoscopy, esophagoscopy, and barium swallow. Patients with liver or bone metastasis were excluded. The majority of patients received preoperative enteral hyperalimentation.

Eighteen of the 20 patients completed the study with a follow-up of 12 to 24 months. There was 1 operative death, and 3 patients were in the hospital for more than three weeks after operation before they were discharged. Fourteen of the 18 patients survived for a year, and 11 survived for 12 to 24 months. Substantial reduction in mucosal disease and tumor burden based on preoperative barium swallow and endoscopy was evident in 11 of 18 patients, but in no patient was the tumor completely eradicated by preoperative chemotherapy. Although follow-up is short, this treatment regimen involving a combined treatment offers hope in the palliation of this disease.

This article has been cited by other articles:

				M. B. Orringer, A. A. Forastiere, C. Perez-Tamayo, S. Urba, B. J. Takasugi, and J. Bromberg Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma Ann. Thorac. Surg., March 1, 1990; 49(3): 348 - 355. [Abstract] [PDF]

				J. R. Hankins, J. E. Miller, S. Attar, and J. S. McLaughlin Transhiatal Esophagectomy for Carcinoma of the Esophagus: Experience with 26 Patients Ann. Thorac. Surg., August 1, 1987; 44(2): 123 - 127. [Abstract] [PDF]